270 related articles for article (PubMed ID: 21820344)
1. Safety, efficacy and physiological actions of a lysine-free, arginine-rich formula to treat glutaryl-CoA dehydrogenase deficiency: focus on cerebral amino acid influx.
Strauss KA; Brumbaugh J; Duffy A; Wardley B; Robinson D; Hendrickson C; Tortorelli S; Moser AB; Puffenberger EG; Rider NL; Morton DH
Mol Genet Metab; 2011; 104(1-2):93-106. PubMed ID: 21820344
[TBL] [Abstract][Full Text] [Related]
2. Complementary dietary treatment using lysine-free, arginine-fortified amino acid supplements in glutaric aciduria type I - A decade of experience.
Kölker S; Boy SP; Heringer J; Müller E; Maier EM; Ensenauer R; Mühlhausen C; Schlune A; Greenberg CR; Koeller DM; Hoffmann GF; Haege G; Burgard P
Mol Genet Metab; 2012 Sep; 107(1-2):72-80. PubMed ID: 22520952
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic modulation of cerebral L-lysine metabolism in a mouse model for glutaric aciduria type I.
Sauer SW; Opp S; Hoffmann GF; Koeller DM; Okun JG; Kölker S
Brain; 2011 Jan; 134(Pt 1):157-70. PubMed ID: 20923787
[TBL] [Abstract][Full Text] [Related]
4. Glutaric acidemia type 1: Treatment and outcome of 168 patients over three decades.
Strauss KA; Williams KB; Carson VJ; Poskitt L; Bowser LE; Young M; Robinson DL; Hendrickson C; Beiler K; Taylor CM; Haas-Givler B; Hailey J; Chopko S; Puffenberger EG; Brigatti KW; Miller F; Morton DH
Mol Genet Metab; 2020 Nov; 131(3):325-340. PubMed ID: 33069577
[TBL] [Abstract][Full Text] [Related]
5. Inherited Disorders of Lysine Metabolism: A Review.
Bouchereau J; Schiff M
J Nutr; 2020 Oct; 150(Suppl 1):2556S-2560S. PubMed ID: 33000154
[TBL] [Abstract][Full Text] [Related]
6. Low lysine diet in glutaric aciduria type I--effect on anthropometric and biochemical follow-up parameters.
Boy N; Haege G; Heringer J; Assmann B; Mühlhausen C; Ensenauer R; Maier EM; Lücke T; Hoffmann GF; Müller E; Burgard P; Kölker S
J Inherit Metab Dis; 2013 May; 36(3):525-33. PubMed ID: 22971958
[TBL] [Abstract][Full Text] [Related]
7. Cerebral haemodynamics in patients with glutaryl-coenzyme A dehydrogenase deficiency.
Strauss KA; Donnelly P; Wintermark M
Brain; 2010 Jan; 133(Pt 1):76-92. PubMed ID: 20032085
[TBL] [Abstract][Full Text] [Related]
8. Clinical course, early diagnosis, treatment, and prevention of disease in glutaryl-CoA dehydrogenase deficiency.
Hoffmann GF; Athanassopoulos S; Burlina AB; Duran M; de Klerk JB; Lehnert W; Leonard JV; Monavari AA; Müller E; Muntau AC; Naughten ER; Plecko-Starting B; Superti-Furga A; Zschocke J; Christensen E
Neuropediatrics; 1996 Jun; 27(3):115-23. PubMed ID: 8837070
[TBL] [Abstract][Full Text] [Related]
9. Glutaric acidemia type 1: outcomes before and after expanded newborn screening.
Viau K; Ernst SL; Vanzo RJ; Botto LD; Pasquali M; Longo N
Mol Genet Metab; 2012 Aug; 106(4):430-8. PubMed ID: 22728054
[TBL] [Abstract][Full Text] [Related]
10. [Glutaric aciduria type I: an organic acidemia without acidosis with severe movement disorders].
Prats Viñas J
Neurologia; 2001 Oct; 16(8):337-41. PubMed ID: 11738010
[No Abstract] [Full Text] [Related]
11. Dietary practices in glutaric aciduria type 1 over 16 years.
Gokmen-Ozel H; MacDonald A; Daly A; Ashmore C; Preece MA; Hendriksz C; Vijay S; Chakrapani A
J Hum Nutr Diet; 2012 Dec; 25(6):514-9. PubMed ID: 22845646
[TBL] [Abstract][Full Text] [Related]
12. Elevated levels of BDNF and cathepsin-d as possible peripheral markers of neurodegeneration in plasma of patients with glutaric acidemia type I.
Guerreiro G; Diaz Jaques CE; Wajner M; Vargas CR
Int J Dev Neurosci; 2020 Feb; 80(1):42-49. PubMed ID: 31910296
[TBL] [Abstract][Full Text] [Related]
13. Multifactorial modulation of susceptibility to l-lysine in an animal model of glutaric aciduria type I.
Sauer SW; Opp S; Komatsuzaki S; Blank AE; Mittelbronn M; Burgard P; Koeller DM; Okun JG; Kölker S
Biochim Biophys Acta; 2015 May; 1852(5):768-77. PubMed ID: 25558815
[TBL] [Abstract][Full Text] [Related]
14. Favourable outcome in a child with symptomatic diagnosis of Glutaric aciduria type 1 despite vertical HIV infection and minor head trauma.
Thomas A; Dobbels EFM; Springer PE; Ackermann C; Cotton MF; Laughton B
Metab Brain Dis; 2018 Apr; 33(2):537-544. PubMed ID: 29427049
[TBL] [Abstract][Full Text] [Related]
15. [Development of brain atrophy, therapy and therapy monitoring in glutaric aciduria type I (glutaryl-CoA dehydrogenase deficiency)].
Lawrenz-Wolf B; Herberg KP; Hoffmann GF; Hunneman DH; Lehnert W; Hanefeld F
Klin Padiatr; 1993; 205(1):23-9. PubMed ID: 8445849
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of L-carnitine on behavioral alterations and neuroinflammation in striatum of glutaryl-COA dehydrogenase deficient mice.
Guerreiro G; Faverzani J; Moura AP; Volfart V; Gome Dos Reis B; Sitta A; Gonzalez EA; de Lima Rosa G; Coitinho AS; Baldo G; Wajner M; Vargas CR
Arch Biochem Biophys; 2021 Sep; 709():108970. PubMed ID: 34181873
[TBL] [Abstract][Full Text] [Related]
17. Glutaric aciduria type I: outcome of patients with early- versus late-diagnosis.
Couce ML; López-Suárez O; Bóveda MD; Castiñeiras DE; Cocho JA; García-Villoria J; Castro-Gago M; Fraga JM; Ribes A
Eur J Paediatr Neurol; 2013 Jul; 17(4):383-9. PubMed ID: 23395213
[TBL] [Abstract][Full Text] [Related]
18. Reversible brain atrophy in glutaric aciduria type 1.
Numata-Uematsu Y; Sakamoto O; Kakisaka Y; Okubo Y; Oikawa Y; Arai-Ichinoi N; Kure S; Uematsu M
Brain Dev; 2017 Jun; 39(6):532-535. PubMed ID: 28143689
[TBL] [Abstract][Full Text] [Related]
19. Marked reduction of Na(+), K(+)-ATPase and creatine kinase activities induced by acute lysine administration in glutaryl-CoA dehydrogenase deficient mice.
Amaral AU; Cecatto C; Seminotti B; Zanatta Â; Fernandes CG; Busanello EN; Braga LM; Ribeiro CA; de Souza DO; Woontner M; Koeller DM; Goodman S; Wajner M
Mol Genet Metab; 2012 Sep; 107(1-2):81-6. PubMed ID: 22578804
[TBL] [Abstract][Full Text] [Related]
20. The long-term treatment of a patient with type 1 diabetes mellitus and glutaric aciduria type 1: the effect of insulin.
Del Rizzo M; Galderisi A; Celato A; Furlan F; Giordano L; Cazzorla C; Fasan I; Moretti C; Zschocke J; Burlina AB
Eur J Pediatr; 2016 Aug; 175(8):1123-8. PubMed ID: 26847429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
